In addition to DLBCL, a subset of multiple myeloma (MM) tumors display globally elevated H3K27me3 levels due to either inactivation of H3K27 demethylases (UTX/KDM6A) or overexpression of PHF1955,56. The gene discussed is KDM6A; the disease is Miyoshi myopathy.